Hempalta Corp. (CVE:HEMP – Get Free Report) Director Darren Hartley Bondar sold 453,000 shares of the company’s stock in a transaction on Monday, January 6th. The stock was sold at an average price of C$0.06, for a total transaction of C$26,274.00.
Darren Hartley Bondar also recently made the following trade(s):
- On Wednesday, January 8th, Darren Hartley Bondar purchased 50,000 shares of Hempalta stock. The shares were bought at an average price of C$0.06 per share, for a total transaction of C$3,000.00.
- On Monday, December 30th, Darren Hartley Bondar acquired 50,000 shares of Hempalta stock. The stock was bought at an average price of C$0.04 per share, with a total value of C$2,000.00.
- On Tuesday, December 24th, Darren Hartley Bondar bought 310,474 shares of Hempalta stock. The stock was purchased at an average cost of C$0.05 per share, with a total value of C$14,499.14.
- On Tuesday, November 5th, Darren Hartley Bondar purchased 200,000 shares of Hempalta stock. The stock was purchased at an average cost of C$0.04 per share, for a total transaction of C$8,000.00.
- On Monday, October 14th, Darren Hartley Bondar acquired 135,000 shares of Hempalta stock. The shares were purchased at an average cost of C$0.04 per share, with a total value of C$5,400.00.
Hempalta Stock Up 18.2 %
Shares of Hempalta stock opened at C$0.07 on Friday. Hempalta Corp. has a 1 year low of C$0.04 and a 1 year high of C$0.30. The firm has a market cap of C$6.17 million, a price-to-earnings ratio of -0.52 and a beta of -0.10. The company has a 50-day moving average of C$0.04 and a 200 day moving average of C$0.10. The company has a debt-to-equity ratio of 28.72, a current ratio of 3.99 and a quick ratio of 0.88.
Hempalta Company Profile
Hempalta Corp., an agricultural cleantech company, produces and processes industrial hemp in North America. It manufactures products using a process known as HempTrain that enables to produce a range of hemp-based commercial and consumer products. The company also engages in the hemp carbon credit market.
Featured Articles
- Five stocks we like better than Hempalta
- Comparing and Trading High PE Ratio Stocks
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- Investing in Construction Stocks
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year
Receive News & Ratings for Hempalta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hempalta and related companies with MarketBeat.com's FREE daily email newsletter.